News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,338 Results
Type
Article (41193)
Company Profile (265)
Press Release (685864)
Multimedia
Podcasts (88)
Webinars (20)
Section
Business (204774)
Career Advice (2028)
Deals (35559)
Drug Delivery (126)
Drug Development (81465)
Employer Resources (173)
FDA (16478)
Job Trends (14969)
News (346667)
Policy (32748)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2592)
Accelerated approval (43)
Adcomms (25)
Allergies (164)
Alliances (49579)
ALS (196)
Alzheimer's disease (1753)
Antibody-drug conjugate (ADC) (392)
Approvals (16815)
Artificial intelligence (609)
Autoimmune disease (235)
Automation (51)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (208)
Biotechnology (174)
Bladder cancer (179)
Brain cancer (66)
Breast cancer (695)
Cancer (5438)
Cardiovascular disease (452)
Career advice (1718)
Career pathing (41)
CAR-T (305)
CDC (54)
Celiac Disease (2)
Cell therapy (808)
Cervical cancer (43)
Clinical research (70349)
Collaboration (1958)
Company closure (4)
Compensation (1304)
Complete response letters (74)
COVID-19 (2730)
CRISPR (100)
C-suite (1023)
Cystic fibrosis (149)
Data (7210)
Decentralized trials (3)
Denatured (26)
Depression (154)
Dermatology (69)
Diabetes (553)
Diagnostics (6858)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (302)
Drug pricing (195)
Drug shortages (31)
Duchenne muscular dystrophy (267)
Earnings (91161)
Editorial (61)
Employer branding (21)
Employer resources (152)
Events (118599)
Executive appointments (1047)
FDA (19979)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1647)
Gene editing (214)
Generative AI (54)
Gene therapy (657)
GLP-1 (1024)
Government (4707)
Grass and pollen (6)
Guidances (400)
Healthcare (18959)
HIV (76)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (276)
Immuno-oncology (85)
Indications (163)
Infectious disease (3056)
Inflammatory bowel disease (202)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (277)
Interviews (316)
IPO (16653)
IRA (50)
Job creations (3646)
Job search strategy (1430)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (556)
Leadership (35)
Legal (7951)
Liver cancer (98)
Longevity (29)
Lung cancer (729)
Lymphoma (411)
Machine learning (54)
Management (59)
Manufacturing (956)
MASH (178)
Medical device (13875)
Medtech (13957)
Mergers & acquisitions (20089)
Metabolic disorders (1426)
mRNA (178)
Multiple sclerosis (177)
NASH (17)
Neurodegenerative disease (385)
Neuropsychiatric disorders (97)
Neuroscience (3171)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4525)
Now hiring (74)
Obesity (672)
Opinion (279)
Ovarian cancer (196)
Pain (235)
Pancreatic cancer (264)
Parkinson's disease (345)
Partnered (33)
Patents (562)
Patient recruitment (615)
Peanut (60)
People (59346)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21921)
Phase 2 (30976)
Phase 3 (23061)
Pipeline (7434)
Policy (306)
Postmarket research (2566)
Preclinical (9302)
Press Release (64)
Prostate cancer (281)
Psychedelics (49)
Radiopharmaceuticals (313)
Rare diseases (1001)
Real estate (5963)
Recruiting (70)
Regulatory (25073)
Reports (54)
Research institute (2408)
Resumes & cover letters (353)
Rett syndrome (33)
RNA editing (18)
RSV (87)
Schizophrenia (167)
Series A (271)
Series B (205)
Service/supplier (12)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3627)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (60)
Vaccines (1064)
Venture capital (99)
Weight loss (430)
Women's health (114)
Worklife (20)
Date
Today (150)
Last 7 days (600)
Last 30 days (2624)
Last 365 days (30134)
2026 (9064)
2025 (30173)
2024 (35216)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (738)
Alabama (91)
Alaska (7)
Arizona (335)
Arkansas (14)
Asia (39513)
Australia (6471)
California (12457)
Canada (3580)
China (1254)
Colorado (535)
Connecticut (540)
Delaware (375)
Europe (85365)
Florida (1884)
Georgia (402)
Hawaii (3)
Idaho (62)
Illinois (991)
India (84)
Indiana (575)
Iowa (22)
Japan (503)
Kansas (129)
Kentucky (46)
Louisiana (38)
Maine (75)
Maryland (1503)
Massachusetts (8905)
Michigan (349)
Minnesota (685)
Mississippi (6)
Missouri (142)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (83)
New Jersey (3320)
New Mexico (28)
New York (3287)
North Carolina (1581)
North Dakota (8)
Northern California (6178)
Ohio (373)
Oklahoma (23)
Oregon (41)
Pennsylvania (2525)
Puerto Rico (28)
Rhode Island (50)
South America (1112)
South Carolina (82)
South Dakota (2)
Southern California (4903)
Tennessee (201)
Texas (1970)
United States (44174)
Utah (377)
Vermont (1)
Virginia (295)
Washington D.C. (80)
Washington State (1002)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
727,338 Results for "pharmalogical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics’ Phase 1/2 Study of a Novel FAP-Targeted Radiopharmaceutical in Late-Stage Aggressive Sarcomas
December 17, 2025
·
4 min read
Press Releases
PharmaLogic Completes Acquisition of Majority Stake in Agilera Pharma AS
June 23, 2025
·
3 min read
Press Releases
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
June 2, 2025
·
2 min read
BioMidwest
Ratio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted Radiopharmaceuticals
Ratio Therapeutics Inc. announced an expanded manufacturing agreement with PharmaLogic, a world-class contract development and manufacturing organization specializing in radiopharmaceutical production and distribution.
March 12, 2024
·
3 min read
BioMidwest
Meilleur Technologies Inc. Announces Execution of Manufacturing Agreement with PharmaLogic for Production of the Next-Generation Amyloid PET Imaging Biomarker, NAV4694
Meilleur Technologies Inc. announced it has signed an agreement with PharmaLogic Holdings Corporation granting PharmaLogic the rights to manufacture fluorine-18 [F18]NAV4694, a next-generation investigational imaging biomarker used in Positron Emission Tomography imaging studies to assess the status of amyloid plaque in the brain.
December 20, 2023
·
2 min read
Press Releases
PharmaLogic to Acquire Majority Stake in Agilera, Strengthening Global Expertise in Radiopharmaceutical Therapeutics
April 10, 2025
·
5 min read
Business
PharmaLogic announces opening of new state-of-the-art radiopharmaceutical production facility in Cincinnati
PharmaLogic Holdings Corp. announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio.
April 22, 2024
·
2 min read
Business
PharmaLogic announces opening of radiopharmaceutical production facility in New York City
PharmaLogic Holdings Corp., a world-class contract development and manufacturing organization and radiopharmacy solutions provider, celebrates the opening of its radiopharmaceutical production and research facility in the Bronx, New York.
May 13, 2024
·
2 min read
Business
Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
Nusano, Inc. and PharmaLogic today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.
May 15, 2023
·
3 min read
Press Releases
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Cincinnati, OH
October 30, 2024
·
5 min read
1 of 72,734
Next
